Observational studyJournal of diabetes research2022

Comparative Assessment of the Long-Term Effectiveness and Safety of Dapagliflozin and Empagliflozin as Add-on Therapy to Hypoglycemic Drugs in Patients with Type 2 Diabetes.

Ai-Yu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.